Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up
1999

Breast Cancer Prognosis Using Invasion and Proliferation Markers

Sample size: 125 publication Evidence: high

Author Information

Author(s): Harbeck N, Dettmar P, Thomssen C, Berger U, Ulm K, Kates R, Höfler H, Jänicke F, Graeff H, Schmitt M

Primary Institution: Technische Universität München

Hypothesis

Can invasion and proliferation markers improve risk-group discrimination in node-negative breast cancer?

Conclusion

PAI-1 is a strong and independent prognostic factor in node-negative breast cancer after a 6-year follow-up.

Supporting Evidence

  • PAI-1 was significant for disease-free survival with a p-value of less than 0.001.
  • The combination of PAI-1 and uPA provided the best risk group discrimination.
  • PAI-1 was the only independently significant factor in Cox analysis for overall survival.

Takeaway

Doctors can use certain markers in breast cancer to better understand how likely a patient is to stay healthy after treatment.

Methodology

The study assessed invasion and proliferation markers in tumor tissue extracts and compared their prognostic impact on disease-free and overall survival.

Participant Demographics

Node-negative breast cancer patients without adjuvant systemic therapy.

Statistical Information

P-Value

P < 0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690373

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication